Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Steroid 5-alpha-reductase | Starlite/ChEMBL | References |
Rattus norvegicus | Androgen Receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Tolloid protein 1 | 0.0284 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.3725 | 1 | 1 |
Echinococcus multilocularis | fibrillin 1 | 0.0284 | 0 | 0.5 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0391 | 0.0313 | 0.5 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0391 | 0.0313 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.1044 | 0.221 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.1044 | 0.221 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.1637 | 0.3933 | 1 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.0391 | 0.0313 | 0.0313 |
Toxoplasma gondii | PAN domain-containing protein | 0.1637 | 0.3933 | 1 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0391 | 0.0313 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1044 | 0.221 | 0.221 |
Loa Loa (eye worm) | NNMT/PNMT/TEMT family protein | 0.3725 | 1 | 1 |
Echinococcus granulosus | laminin | 0.0284 | 0 | 0.5 |
Brugia malayi | Trypsin family protein | 0.1044 | 0.221 | 0.221 |
Echinococcus multilocularis | Tolloid protein 1 | 0.0284 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0391 | 0.0313 | 0.0313 |
Onchocerca volvulus | 0.0888 | 0.1757 | 0.7949 | |
Loa Loa (eye worm) | hypothetical protein | 0.1044 | 0.221 | 0.221 |
Onchocerca volvulus | 0.1044 | 0.221 | 1 | |
Echinococcus multilocularis | laminin | 0.0284 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.3725 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.